Document
... Methotrexate toxicity. An inquiry into the death of a Cambridgeshire patient in April 2000. Cambridge: Cambridgeshire Health Authority; 2000 Methotrexate patient safety solutions – Background briefing. National Patient Safety Agency. Available at http://81.144.177.110/web/display?contentId=2484 Acce ...
... Methotrexate toxicity. An inquiry into the death of a Cambridgeshire patient in April 2000. Cambridge: Cambridgeshire Health Authority; 2000 Methotrexate patient safety solutions – Background briefing. National Patient Safety Agency. Available at http://81.144.177.110/web/display?contentId=2484 Acce ...
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
... suggest that fluvoxamin could be a potential drug for the treatment of delirium in older adults due to sigma-1 receptor agonist activity although they emphasise that a randomized double-blind, placebo-controlled study is necessary to confirm this hypothesis. Pre-existing changes in pharmacokinetics ...
... suggest that fluvoxamin could be a potential drug for the treatment of delirium in older adults due to sigma-1 receptor agonist activity although they emphasise that a randomized double-blind, placebo-controlled study is necessary to confirm this hypothesis. Pre-existing changes in pharmacokinetics ...
CLINICAL PRACTICE GUIDELINES MANAGEMENT OF IMMUNE THROMBOCYTOPENIC
... platelet count. This condition occurs in about 0.1% of adults, and is easily confirmed by the finding of a normal platelet count using a sample taken in citrate or heparin rather than EDTA anticoagulant 8 Level 9. An autoimmune screen should be carried out to exclude other autoimmune diseases which ...
... platelet count. This condition occurs in about 0.1% of adults, and is easily confirmed by the finding of a normal platelet count using a sample taken in citrate or heparin rather than EDTA anticoagulant 8 Level 9. An autoimmune screen should be carried out to exclude other autoimmune diseases which ...
pharmacongress 2008 - Global Health Care, LLC
... 4 companies entered into Deferred Prosecution Agreements (DPAs) Stryker entered into a Non-prosecution Agreement with similar terms Significant new provisions: ...
... 4 companies entered into Deferred Prosecution Agreements (DPAs) Stryker entered into a Non-prosecution Agreement with similar terms Significant new provisions: ...
European S3-Guidelines on the systemic treatment of psoriasis
... deliberately restricted to aspects that the experts felt were especially relevant. Steps that can be considered part of every physician’s general obligations when prescribing drugs (e.g. inquiring about allergies and intolerance reactions, as well as identifying potential contraindications) are not ...
... deliberately restricted to aspects that the experts felt were especially relevant. Steps that can be considered part of every physician’s general obligations when prescribing drugs (e.g. inquiring about allergies and intolerance reactions, as well as identifying potential contraindications) are not ...
CMA Driver’s Guide Determining Medical Fitness to Operate Motor Vehicles 8th edition
... Disclaimer: This guide is not a substitute for medical diagnosis, and readers are encouraged to use their best clinical judgement to determine a patient’s medical fitness to drive. The naming of any organization, product or alternative therapy in this book does not imply endorsement by the Canadian ...
... Disclaimer: This guide is not a substitute for medical diagnosis, and readers are encouraged to use their best clinical judgement to determine a patient’s medical fitness to drive. The naming of any organization, product or alternative therapy in this book does not imply endorsement by the Canadian ...
DRUG NAME: Hydroxyurea
... SIDE EFFECTS: The table includes adverse events that presented during drug treatment but may not necessarily have a causal relationship with the drug. Because clinical trials are conducted under very specific conditions, the adverse event rates observed may not reflect the rates observed in clinical ...
... SIDE EFFECTS: The table includes adverse events that presented during drug treatment but may not necessarily have a causal relationship with the drug. Because clinical trials are conducted under very specific conditions, the adverse event rates observed may not reflect the rates observed in clinical ...
Efficacy of methylsulfonylmethane (MSM)
... Index were reported with MSM, glucosamine sulfate, and their combination (P < 0.05). The authors reported a 33% decrease in pain in the MSM group; joint mobility, swelling, global evaluation, and walking time also improved. MSM safety and toxicity clinical studies have not been published. Acute and ...
... Index were reported with MSM, glucosamine sulfate, and their combination (P < 0.05). The authors reported a 33% decrease in pain in the MSM group; joint mobility, swelling, global evaluation, and walking time also improved. MSM safety and toxicity clinical studies have not been published. Acute and ...
Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the
... Index were reported with MSM, glucosamine sulfate, and their combination (P < 0.05). The authors reported a 33% decrease in pain in the MSM group; joint mobility, swelling, global evaluation, and walking time also improved. MSM safety and toxicity clinical studies have not been published. Acute and ...
... Index were reported with MSM, glucosamine sulfate, and their combination (P < 0.05). The authors reported a 33% decrease in pain in the MSM group; joint mobility, swelling, global evaluation, and walking time also improved. MSM safety and toxicity clinical studies have not been published. Acute and ...
Giving something back to the authors
... hours of symptom onset. Indeed, there were no significant diVerences between the alteplase and placebo groups according to time strata of 0–3 hours and 3–6 hours of stroke onset, although it was not powered to show such a diVerence (only 158 patients in the 0–3 hours subgroup). The overall mortality ...
... hours of symptom onset. Indeed, there were no significant diVerences between the alteplase and placebo groups according to time strata of 0–3 hours and 3–6 hours of stroke onset, although it was not powered to show such a diVerence (only 158 patients in the 0–3 hours subgroup). The overall mortality ...
E 11 Clinical Investigation of Medicinal Products in the
... When a medicinal product is to be used in the pediatric population for the same indication(s) as those studied and approved in adults, the disease process is similar in adults and pediatric patients, and the outcome of therapy is likely to be comparable, extrapolation from adult efficacy data may be ...
... When a medicinal product is to be used in the pediatric population for the same indication(s) as those studied and approved in adults, the disease process is similar in adults and pediatric patients, and the outcome of therapy is likely to be comparable, extrapolation from adult efficacy data may be ...
Supplement November 2008 Optimal Treatment of Chronic Constipation in Managed Care:
... Abstract BACKGROUND: Prevalence studies estimate that chronic constipation affects 12%-19% of Americans. This prevalence rate exceeds that of many highly publicized chronic conditions, including diabetes and asthma. Identifying the etiology of each patient’s constipation is essential for determining ...
... Abstract BACKGROUND: Prevalence studies estimate that chronic constipation affects 12%-19% of Americans. This prevalence rate exceeds that of many highly publicized chronic conditions, including diabetes and asthma. Identifying the etiology of each patient’s constipation is essential for determining ...
View the 2016 Prior Authorization Criteria
... cell or non-clear cell histology. If clear cell histology, the patient has previous tried and failed Votrient (pazopanib) or Sutent (sunitinib). For classical Hodgkin lymphoma, Afinitor will be used as a single agent. For advanced breast cancer, patient has advanced hormone receptor positive, HER2 n ...
... cell or non-clear cell histology. If clear cell histology, the patient has previous tried and failed Votrient (pazopanib) or Sutent (sunitinib). For classical Hodgkin lymphoma, Afinitor will be used as a single agent. For advanced breast cancer, patient has advanced hormone receptor positive, HER2 n ...
AROPAX® PRODUCT INFORMATION (paroxetine)
... antidepressants. There is also some evidence that paroxetine may be of therapeutic value in patients who have failed to respond to standard therapy. In general, improvement in patients starts after one week but does not become superior to placebo until the second week of therapy. AROPAX is effective ...
... antidepressants. There is also some evidence that paroxetine may be of therapeutic value in patients who have failed to respond to standard therapy. In general, improvement in patients starts after one week but does not become superior to placebo until the second week of therapy. AROPAX is effective ...
Management of adults with diabetes on the
... patients with diabetes on maintenance haemodialysis, however, its use is limited by technical issues relating to device calibration, which must be taken into account for accurate interpretation of data. (Grade 1C) 2.8 When using CGM, it is advised to commence the CGM on a non-dialysis day to minimi ...
... patients with diabetes on maintenance haemodialysis, however, its use is limited by technical issues relating to device calibration, which must be taken into account for accurate interpretation of data. (Grade 1C) 2.8 When using CGM, it is advised to commence the CGM on a non-dialysis day to minimi ...
Anticoagulation in patients with impaired renal function and with
... Data from animal studies and healthy volunteers suggest that, with heparin dosages <100 U/kg, clearance of UFH occurs mainly via the RES and the endothelium (16). Only at higher doses, some intact heparin molecules are recovered in the urine. The half-life of UFH appears to be slightly prolonged, by ...
... Data from animal studies and healthy volunteers suggest that, with heparin dosages <100 U/kg, clearance of UFH occurs mainly via the RES and the endothelium (16). Only at higher doses, some intact heparin molecules are recovered in the urine. The half-life of UFH appears to be slightly prolonged, by ...
Fluticasone Propionate Ointment, 0.005%
... production, or cause other untoward effects. It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk. Because many drugs are excreted in human milk, caution should be exercised when Fluticasone Pr ...
... production, or cause other untoward effects. It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk. Because many drugs are excreted in human milk, caution should be exercised when Fluticasone Pr ...
Application for Inclusion of MILTEFOSINE On WHO Model List of
... St-Laurent, Québec, Canada H4M 2P2 Tel: (514) 669-5323 [email protected] ...
... St-Laurent, Québec, Canada H4M 2P2 Tel: (514) 669-5323 [email protected] ...
Evaluation and Management Issues in Migraine
... fluctuations), which are widely recognized to trigger or aggravate migraine in susceptible individuals, overuse of abortive medications may paradoxically worsen headache. In particular, the frequent use of ergotamine and caffeine-containing medications appears to be a potent cause of what has been t ...
... fluctuations), which are widely recognized to trigger or aggravate migraine in susceptible individuals, overuse of abortive medications may paradoxically worsen headache. In particular, the frequent use of ergotamine and caffeine-containing medications appears to be a potent cause of what has been t ...
product information
... (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated. LIPITOR is indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD) ...
... (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated. LIPITOR is indicated in hypertensive patients with multiple risk factors for coronary heart disease (CHD) ...
S3 File.
... efficacy for different types of tremor. The present study aims to fill this knowledge gap by investigating the differential effect of Xeomin® on ET compared to IPD. Advantages of BoNT A To date, efficacy in treatment of essential tremor by oral medication has been sup-optimal for all individuals. Pr ...
... efficacy for different types of tremor. The present study aims to fill this knowledge gap by investigating the differential effect of Xeomin® on ET compared to IPD. Advantages of BoNT A To date, efficacy in treatment of essential tremor by oral medication has been sup-optimal for all individuals. Pr ...
Japanese guidelines for adult asthma 2017
... Asthma prevalence has rapidly increased in recent years. An International Study of Asthma and Allergies in Childhood (ISAAC) survey has been conducted across Japan to assess the prevalence of asthma at specific time points. The mean prevalence of asthma in Japan has increased from about 1% to 10% or ...
... Asthma prevalence has rapidly increased in recent years. An International Study of Asthma and Allergies in Childhood (ISAAC) survey has been conducted across Japan to assess the prevalence of asthma at specific time points. The mean prevalence of asthma in Japan has increased from about 1% to 10% or ...
update on the mechanisms, assessment, and management of dyspnea
... breathlessness may be perceived as a threat associated with anxiety, fear, or depression, and it may be viewed as a sign of disease. The individual may avoid activities that precipitate the symptom, thereby becoming more sedentary and increasingly unfit (33). The high prevalence of anxiety and depre ...
... breathlessness may be perceived as a threat associated with anxiety, fear, or depression, and it may be viewed as a sign of disease. The individual may avoid activities that precipitate the symptom, thereby becoming more sedentary and increasingly unfit (33). The high prevalence of anxiety and depre ...